Chad Therapeutics Posts Net Loss for 1st Quarter
Chad Therapeutics Inc., Chatsworth, announced a net loss of $154,000 for the first quarter ended June 30, compared with net earnings of $107,000 for the same quarter last year. Sales fell 13% to $3.6 million, compared with $4.2 million.
Chad produces and distributes supplemental oxygen systems and conservation devices for pulmonary patients.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
